Ellis PG - Search Results

1

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine.

Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, Panella TJ, Jordan VC, Fine RL. Trump DL, et al. Among authors: ellis pg. J Natl Cancer Inst. 1992 Dec 2;84(23):1811-6. doi: 10.1093/jnci/84.23.1811. J Natl Cancer Inst. 1992. PMID: 1359155 Clinical Trial.

2

Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.

Smith DC, Jodrell DI, Egorin MJ, Ambinder RM, Zuhowski EG, Kreis W, Ellis PG, Trump DL. Smith DC, et al. Among authors: ellis pg. Cancer Chemother Pharmacol. 1993;31(5):363-8. doi: 10.1007/BF00686149. Cancer Chemother Pharmacol. 1993. PMID: 7679331 Clinical Trial.

3

A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer.

Loesch DM, Asmar L, Canfield VA, Parker GA, Hynes HE, Ellis PG, Ferri WA Jr, Robert NJ. Loesch DM, et al. Among authors: ellis pg. Breast Cancer Res Treat. 2003 Jan;77(2):115-23. doi: 10.1023/a:1021384318470. Breast Cancer Res Treat. 2003. PMID: 12602910 Clinical Trial.

4

System-Level Factors Associated With Use of Outpatient Specialty Palliative Care Among Patients With Advanced Cancer.

Yu JA, Ray KN, Park SY, Barry A, Smith CB, Ellis PG, Schenker Y. Yu JA, et al. Among authors: ellis pg. J Oncol Pract. 2019 Jan;15(1):e10-e19. doi: 10.1200/JOP.18.00234. Epub 2018 Nov 8. J Oncol Pract. 2019. PMID: 30407881 Free PMC article.

5

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.

Mason C, Ellis PG, Lokay K, Barry A, Dickson N, Page R, Polite B, Salgia R, Savin M, Shamah C, Socinski MA. Mason C, et al. Among authors: ellis pg. J Clin Pathw. 2018 Jan-Feb;4(1):49-54. doi: 10.25270/jcp.2018.02.00001. J Clin Pathw. 2018. PMID: 31453358 Free PMC article.

6

Clinical Pathways: Management of Quality and Cost in Oncology Networks in the Metastatic Colorectal Cancer Setting.

Ellis PG, O'Neil BH, Earle MF, McCutcheon S, Benson H, Krebs M, Lokay K, Barry A. Ellis PG, et al. J Oncol Pract. 2017 May;13(5):e522-e529. doi: 10.1200/JOP.2016.019232. Epub 2017 Apr 5. J Oncol Pract. 2017. PMID: 28379722

7

Pathways Clinical Decision Support for Appropriate Use of Key Biomarkers.

Ellis PG, Brufsky AM, Beriwal S, Lokay KG, Benson HO, McCutcheon SB, Krebs M. Ellis PG, et al. J Oncol Pract. 2016 Jun;12(6):e681-7. doi: 10.1200/JOP.2015.010546. Epub 2016 May 24. J Oncol Pract. 2016. PMID: 27221995

8

Development and implementation of oncology care pathways in an integrated care network: the Via Oncology Pathways experience.

Ellis PG. Ellis PG. J Oncol Pract. 2013 May;9(3):171-3. doi: 10.1200/JOP.2013.001020. J Oncol Pract. 2013. PMID: 23942503 Free PMC article.

9

Payer and provider collaborations that improve quality outcomes in oncology.

Dunn JD, Ellis PG, Fox JL, Klein I, Lopes M, Nash DB, Nishida L, Schwartzberg LS, Wong W. Dunn JD, et al. Among authors: ellis pg. Manag Care. 2010 Nov;19(11):35-40, 42. Manag Care. 2010. PMID: 21141375 No abstract available.

10

An examination of the calcium and phosphorus nutrition of thoroughbred racehorses.

Caple IW, Bourke JM, Ellis PG. Caple IW, et al. Among authors: ellis pg. Aust Vet J. 1982 Apr;58(4):132-5. doi: 10.1111/j.1751-0813.1982.tb00622.x. Aust Vet J. 1982. PMID: 7126062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters